Medical Software Company Investment Opportunity in Mumbai, India
Established | 5-10 year(s) |
Employees | 5 - 10 |
Legal Entity | Private Limited Company |
Reported Sales | Nil |
Run Rate Sales | Nil |
EBITDA Margin | Nil |
Industries | Medical Software |
Locations | Mumbai |
Local Time | 8:10 AM Asia / Kolkata |
Listed By | Business Owner / Director |
Status | Moderately Active |
- Operates on a pay-per-use model where doctors use the software for each patient screening.
- Currently in pre-revenue phase, but selected for top programs like Cornell Maha60 and Stanford Seed, reflecting strong validation.
- Recognized globally as a semi-finalist in a Boston Scientific competition, showing industry relevance.
- Backed by scientific credibility through a published paper with Springer.
- Operates with a lean team of 6 employees, outsourcing R&D to stay efficient and innovative.
- Plans to scale using a SaaS model to create recurring revenue and expand reach across healthcare providers.
- A software-based diagnostic tool for early screening of Peripheral Artery Disease (PAD)
- Cloud-based platform to manage and analyze test results.
Who will use them:
- Doctors and medical professionals in clinics and hospitals.
- Healthcare institutions focused on cardiovascular health and preventive care.
- Patients indirectly benefit through early detection and diagnosis via these medical professionals.
The software is used by doctors to conduct non-invasive PAD tests, and the business earns revenue each time a test is performed.
The intangible assets include:
- Source code for the product.
- Research and development reports.
There are no debts in the business.